OBJECTIVES: We have preciously documented that many individuals with acute mania have immune activation. However, the sources of immune activation have not been identified. We investigated whether individuals hospitalized with acute mania have evidence of bacterial infections as determined by the prescription of systemic antimicrobial agents. METHODS: We assessed the recent prescription of systemic antimicrobial medications and the site of presumed bacterial infection in 234 individuals hospitalized for acute mania in either an inpatient unit or a day hospital. We also assessed individuals hospitalized for other psychiatric disorders (n=368) and controls (n=555). We employed logistic regression models to compare the rates of antibiotic prescription in individuals with the different diagnoses, employing demographic variables as covariates. RESULTS: We found that individuals hospitalized with acute mania had a substantially increased rate of recent antimicrobial prescription, defined as exposure within three days of ascertainment (adjusted odds ratio=5.5, 95% confidence interval: 2.2-14.1, P<.0002). Overall, a total of 18 of the 234 (7.7%) individuals hospitalized for acute mania were prescribed antibiotics as opposed to seven of 555 (1.3%) controls. The prescription of antibiotics was associated with being on an inpatient unit as opposed to being in the day hospital, and having increased mania symptom severity but not with other clinical ratings, demographic variables, or psychiatric medications. Hospitalization for other psychiatric disorders was not associated with the recent prescription of antimicrobial medications. The urinary tract was the most common site of infection in women, while the respiratory tract and mucosal surfaces were the most common sites in men. CONCLUSIONS: Individuals hospitalized with acute mania have a markedly increased rate of bacterial infections, as evidenced by the recent prescription of antimicrobial agents. The prevention and effective treatment of bacterial infections may be important interventions for the management of individuals with mania.
OBJECTIVES: We have preciously documented that many individuals with acute mania have immune activation. However, the sources of immune activation have not been identified. We investigated whether individuals hospitalized with acute mania have evidence of bacterial infections as determined by the prescription of systemic antimicrobial agents. METHODS: We assessed the recent prescription of systemic antimicrobial medications and the site of presumed bacterial infection in 234 individuals hospitalized for acute mania in either an inpatient unit or a day hospital. We also assessed individuals hospitalized for other psychiatric disorders (n=368) and controls (n=555). We employed logistic regression models to compare the rates of antibiotic prescription in individuals with the different diagnoses, employing demographic variables as covariates. RESULTS: We found that individuals hospitalized with acute mania had a substantially increased rate of recent antimicrobial prescription, defined as exposure within three days of ascertainment (adjusted odds ratio=5.5, 95% confidence interval: 2.2-14.1, P<.0002). Overall, a total of 18 of the 234 (7.7%) individuals hospitalized for acute mania were prescribed antibiotics as opposed to seven of 555 (1.3%) controls. The prescription of antibiotics was associated with being on an inpatient unit as opposed to being in the day hospital, and having increased mania symptom severity but not with other clinical ratings, demographic variables, or psychiatric medications. Hospitalization for other psychiatric disorders was not associated with the recent prescription of antimicrobial medications. The urinary tract was the most common site of infection in women, while the respiratory tract and mucosal surfaces were the most common sites in men. CONCLUSIONS: Individuals hospitalized with acute mania have a markedly increased rate of bacterial infections, as evidenced by the recent prescription of antimicrobial agents. The prevention and effective treatment of bacterial infections may be important interventions for the management of individuals with mania.
Authors: Angelica de Baumont; Mariana Maschietto; Leandro Lima; Dirce Maria Carraro; Eloisa Helena Olivieri; Alex Fiorini; Luiz André Nardin Barreta; Joana Almeida Palha; Paulo Belmonte-de-Abreu; Carlos Alberto Moreira Filho; Helena Brentani Journal: Schizophr Res Date: 2014-12-06 Impact factor: 4.939
Authors: Åsa Blomström; Håkan Karlsson; Anna Svensson; Thomas Frisell; Brian K Lee; Henrik Dal; Cecilia Magnusson; Christina Dalman Journal: Schizophr Bull Date: 2013-12-23 Impact factor: 9.306
Authors: Michael E Benros; Berit L Waltoft; Merete Nordentoft; Søren D Ostergaard; William W Eaton; Jesper Krogh; Preben B Mortensen Journal: JAMA Psychiatry Date: 2013-08 Impact factor: 21.596
Authors: Jacek Karczewski; Aleksandra Zielińska; Rafał Staszewski; Piotr Eder; Agnieszka Dobrowolska; Eliana B Souto Journal: Int J Mol Sci Date: 2022-05-30 Impact factor: 6.208
Authors: Thomaz F S Bastiaanssen; Caitlin S M Cowan; Marcus J Claesson; Timothy G Dinan; John F Cryan Journal: Int J Neuropsychopharmacol Date: 2019-01-01 Impact factor: 5.176
Authors: Lorenza Lucidi; Mauro Pettorruso; Federica Vellante; Francesco Di Carlo; Franca Ceci; Maria Chiara Santovito; Ilenia Di Muzio; Michele Fornaro; Antonio Ventriglio; Carmine Tomasetti; Alessandro Valchera; Alessandro Gentile; Yong-Ku Kim; Giovanni Martinotti; Silvia Fraticelli; Massimo Di Giannantonio; Domenico De Berardis Journal: Int J Mol Sci Date: 2021-04-02 Impact factor: 5.923
Authors: Fredrik Upmark; Hugo Sjöqvist; Joseph F Hayes; Christina Dalman; Håkan Karlsson Journal: Transl Psychiatry Date: 2021-09-08 Impact factor: 6.222